Nuvisan Email Formats

Pharmaceutical Manufacturing • Neu Ulm, Bavaria, Germany • 501-1000 Employees

Nuvisan Email Formats

Nuvisan uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@nuvisan.com), used 56.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@nuvisan.com	58%
{first initial}.{last name}	j.doe@nuvisan.com	39.7%

Key Contacts at Nuvisan

Benjamin Bader

Director, Head Of Screening

Andrew Green

Business Development Director Uk & Ireland

Norbert Schmees

Director, Head Of Life Science Chemistry 2

Dirk Scharn

Director, Head Of In Vitro Pk

Stefan Werner

Director, Life Science Chemistry & Analytics At Nuvisan Icb Gmbh, A Division Of Als Limited

Petra Offizorz

Corporate Business & Project Director

Achim Freisleben

Managing Director / Coo

Michaela Golob

Senior Scientific Director, Head Of Immunoassays & Immunology

Thomas Jordan

Director Business Controlling

Sven Kirstein

Director, Head Of Administration & Infrastructure

Company overview

Headquarters	Wegenerstrasse 13, Neu-Ulm, 89231, DE
Phone number	+494973198400
Website	nuvisan.com
NAICS	3254
SIC	283
Keywords	Clinical Development, Pharmacology, Bioinformatics, Chemistry, Structural Biology, Target Identification, Qp Services, Computational Chemistry, Api Manufacturing, Compound Libraries, High-Throughput Screening, Immunogenicity Testing, Hit-To-Lead Optimization, In Vitro & In Vivo Dmpk, In-House Clinical Pharmacology Unit, Radiosynthesis/Isotope Labeling, Small & Large Molecule Bioanalysis, R&D Innovation, Clinical & Medical Monitoring, 2D/3D Modeling, Biomarker Analysis & Discovery, Fragment-Based Drug Design
Employees	501-1000
Socials

About Nuvisan

Your partner of choice in bringing therapeutics to life, Nuvisan is the unique CRO/CDMO with extensive pharma experience and industry-leading scientific expertise, providing highest-quality end-to-end solutions. From enabling target understanding to helping get innovative medicines to the patients who need them, we provide support that streamlines and accelerates drug discovery and development.